A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer - Scorecard - MDSpire

A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer

  • By

  • Qihuan Shen

  • Yuhao Huang

  • Haoran Li

  • Baoying Chen

  • Huadi Shi

  • Zumin Xu

  • April 29, 2026

  • 0 min

Share

Clinical Scorecard: A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationMale patients with metastatic breast cancer, particularly those receiving utidelone.
Care Setting

Key Highlights

  • Atrial fibrillation occurred in a 57-year-old male patient during utidelone infusion.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regular cardiac monitoring and assessment of Pro-BNP levels during utidelone treatment.

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • Initiate cardiac monitoring prior to and during chemotherapy with utidelone, specifically monitoring for atrial fibrillation.

        References

        Original Source(s)

        A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer

        • by Qihuan Shen, Yuhao Huang, Haoran Li, Baoying Chen, Huadi Shi, Zumin Xu

        • April 29, 2026

        Related Content

        Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

        Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

        Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma